Grifols, S.A

(NASDAQ:GRFS)

Latest On Grifols, S.A (GRFS):

Date/Time Type Description Signal Details
2023-05-13 23:16 ESTNewsGrifols: Upside After A Smashing Q1 2023 - I Say 'Buy'N/A
2023-05-10 09:51 ESTNewsGrifols, S.A. (GRFS) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 09:51 ESTNewsGrifols, S.A. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-09 21:01 ESTNewsGrifols S.A. reports Q1 results; raises FY23 guidanceN/A
2023-05-08 18:06 ESTNewsGrifols names new CEO ending founding family’s leadershipN/A
2023-05-08 18:06 ESTNewsGrifols S.A. Q1 2023 Earnings PreviewN/A
2023-03-06 22:10 ESTNewsGrifols, Selagine team up to develop immunoglobulin eye dropsN/A
2023-03-03 14:59 ESTNewsGrifols downgraded at Morgan Stanley citing slower margin recoveryN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. (GRFS) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-27 22:34 ESTNewsGrifols S.A. FY 2022 Earnings PreviewN/A
2023-02-23 08:51 ESTNewsGrifols: A Favorite For Some, Speculative Buy For MeN/A
2023-02-15 18:35 ESTNewsGrifols cuts 8% staff mainly in U.S. as cost savings plan takes effectN/A
2022-12-07 04:30 ESTNewsGrifols upgraded to Overweight at Morgan StanleyN/A
2022-11-18 23:56 ESTNewsGrifols Needs To DeleverageN/A
2022-11-11 02:38 ESTNewsGrifols S.A. reports Q3 resultsN/A
2022-09-08 04:06 ESTNewsGrifols inks 15-year deal with Canada for plasma-derived therapiesN/A
2022-07-29 21:31 ESTNewsGrifols: Every Cloud Has A Silver LiningN/A
2022-05-10 18:31 ESTNewsGrifols: Long OnlyN/A
2022-05-09 20:47 ESTNewsGrifols stock slumps on Spain's stock exchange paring gains seen after Q1 resultsN/A
2022-03-31 03:27 ESTNewsGrifols jumps on report on takeover speculation (update)N/A
2022-03-15 13:03 ESTNewsGrifols ABvac40 vaccine for Alzheimer's shows safety/response in phase 2 interim dataN/A
2022-02-25 00:55 ESTNewsGrifols, Endpoint Health team up to develop Antithrombin III for SepsisN/A
2022-02-10 19:31 ESTNewsGrifols: Short-Term Turbulence But Long-Term UpsideN/A
2022-02-07 14:28 ESTNewsGrifols extends losses as JPMorgan points to downside risk to consensusN/A
2021-12-28 18:43 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-09-22 13:48 ESTNewsGrifols consolidates footprint in blood plasma with agreement to acquire BiotestN/A
2021-07-22 12:25 ESTNewsGrifols launches hepatitis B treatment HyperHEP BN/A
2021-07-22 12:25 ESTNewsGrifols sees revenue contribution from new product launches to ramp by 2030N/A
2021-07-22 12:25 ESTNewsGrifols presents at 2021 investor and analyst day - slideshowN/A
2021-07-22 12:16 ESTNewsGrifols: Valuation Discount Remains Wide Despite An Upbeat Capital Markets DayN/A
2021-06-03 06:11 ESTDividendA dividend of $0.46 has been announced on Nov 30, -0001. It will be paid Jun 14, 2021 with an ex-dividend date of Jun 3, 2021.Neutral
2021-04-29 02:40 ESTNewsGrifols shares rise after Andorra Development and Investment dealN/A
2021-04-21 10:06 ESTNewsGrifols: The Plasma-Supply Disruption Provides An Attractive Entry PointN/A
2021-03-18 23:26 ESTAnalyst RatingThe Analyst Target Price has increased from $27.19 to $27.38.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $1.56 is estimated for the 2022 year.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-17 22:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.31 to $27.19.Neutral
2021-03-16 22:48 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.41 to $27.31.Neutral
2021-03-13 21:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.49 to $32.41.Neutral
2021-03-13 05:02 ESTAnalyst RatingThe Analyst Target Price has increased from $32.34 to $32.49.Buy
2021-03-12 13:01 ESTAnalyst RatingThe Analyst Target Price has increased from $31.97 to $32.34.Buy
2021-03-12 05:18 ESTAnalyst RatingThe Analyst Target Price has increased from $31.9 to $31.97.Buy
2021-03-11 01:24 ESTAnalyst RatingThe Analyst Target Price has increased from $31.77 to $31.9.Buy
2021-03-10 05:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.97 to $31.77.Neutral
2021-03-09 01:14 ESTAnalyst RatingThe Analyst Target Price has increased from $31.93 to $31.97.Buy
2021-03-07 09:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.08 to $31.93.Neutral
2021-03-05 21:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.27 to $32.08.Neutral
2021-03-05 12:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.36 to $32.27.Neutral
2021-03-04 01:27 ESTAnalyst RatingThe Analyst Target Price has increased from $32.26 to $32.36.Buy

About Grifols, S.A (GRFS):

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. It offers intravenous immunoglobin, albumin, alpha-1-antitrypsin, factor VIII, antithrombin, and other specialty hyperimmune immunoglobulins. The Hospital segment offers non-biological pharmaceutical products and medical supplies for hospital pharmacy, such as intravenous solutions, pharmatech solutions, clinical nutrition products, and medical devices for interventional therapy. The Diagnostic segment manufactures and markets diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides engineering services; and rents industrial buildings. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

GRFS Quotes by TradingView

See Advanced Chart

General

  • Name Grifols, S.A
  • Symbol GRFS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 23,655
  • Last Split Factor2:1
  • Last Split Date2016-01-04
  • Fiscal Year EndDecember
  • IPO Date2006-05-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.grifols.com
View More

Valuation

  • Trailing PE 27.04
  • Forward PE 11.99
  • Price/Sales (Trailing 12 Mt.) 1.73
  • Price/Book (Most Recent Quarter) 1.81
  • Enterprise Value Revenue 4.17
  • Enterprise Value EBITDA 15.63
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.34
  • Next Year EPS Estimate $1.57
  • Next Quarter EPS Estimate $0.32
  • Profit Margin 12%
  • Return on Assets 5%
  • Return on Equity 10%
  • Earnings Per Share $0.60
  • Revenue Per Share $0
  • Gross Profit 2.51 billion
  • Quarterly Earnings Growth -3.8%
View More

Highlights

  • Market Capitalization 14.95 billion
  • PE Ratio 37.23
  • PEG Ratio 1.78
  • Analyst Target Price $27.38
  • Book Value Per Share $3.56
View More

Share Statistics

  • Shares Outstanding 684.54 million
  • Shares Float 856.69 million
  • % Held by Insiders <1%
  • % Held by Institutions 45.62%
  • Shares Short 3.8 million
  • Shares Short Prior Month 3.72 million
  • Short Ratio 4.17
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.05
  • 52 Week High $21.62
  • 52 Week Low $14.81
  • 50 Day Moving Average 16.54
  • 200 Day Moving Average 17.73
View More

Dividends

  • Forward Annual Dividend Rate $0.42
  • Forward Annual Dividend Yield 2.55%
  • Payout Ratio 16%
  • Dividend Date 2020-11-09
  • ExDividend Date 2020-10-30
  • Dividend Per Share $0.47
  • Dividend Yield 0%
View More

Grifols, S.A (GRFS) Dividend Calendar:

GRFS's last dividend payment was made to shareholders on November 9, 2020.
Grifols, S.A pays out 16% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2021-06-032021-06-142021-06-040000-00-00$0.46
2020-10-302020-11-092020-11-02$0.2
2019-12-022019-12-112019-12-032019-10-31$0.22
2019-06-072019-06-182019-06-102019-05-29$0.18
2018-11-302018-12-112018-12-032018-11-07$0.23
2018-06-012018-06-122018-06-042018-05-25$0.25
2017-12-012017-12-122017-12-04$0.21
2017-05-302017-06-082017-06-01$0.16
2016-12-052016-12-142016-12-07$0.19
2015-12-102015-12-172015-12-14$0.38
2015-06-082015-06-152015-06-10$0.34
2016-06-020000-00-002016-06-060000-00-00$0.16
2016-06-022016-06-06$0.16

Grifols, S.A (GRFS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$1.31 billion$0.29$0.2515.82%
2020-09-302020-11-05$N/A$0.37$0.356.67%
2020-06-302020-07-30$N/A$0.36$0.37-1.33%
2020-03-312020-04-21$1.29 billion$0.24$0.30-18.58%
2019-12-312020-02-27$1.53 billion$0.31$0.31-1.63%
2019-09-302019-10-29$1.43 billion$0.28$0.30-7.05%
2019-06-302019-07-31$1.43 billion$0.33$0.320.12%
2019-03-312019-05-07$1.3 billion$0.25$0.25-1.32%
2018-12-312019-02-28$1.4 billion$0.24$0.31-22.87%
2018-09-302018-11-05$1.32 billion$0.29$0.31-5.83%
2018-06-302018-07-27$1.28 billion$0.34$0.326.69%
2018-03-312018-05-03$1.26 billion$0.28$0.29-3.76%
2017-12-312018-02-28$1.35 billion$0.29$0.31-8.1%
2017-09-302017-11-02$1.34 billion$0.28$0.30-4.31%
2017-06-302017-07-28$1.37 billion$0.28$0.281.53%
2017-03-312017-05-03$1.14 billion$0.27$0.261.71%
2016-12-312017-02-28$956.29 million$0.25$0.253.59%
2016-09-302016-11-08$1.16 billion$0.28$0.2511.6%
2016-06-302016-07-28$1.06 billion$0.26$0.27-5.56%
2016-03-312016-05-05$1.09 billion$0.23$0.24-4.25%
2015-12-312016-02-29$1.07 billion$0.24$0.27-11.48%
2015-09-302015-11-04$1.09 billion$0.26$0.2218.18%
2015-06-302015-07-30$1.14 billion$0.22$0.23-4.35%
2015-03-312015-05-07$975.7 million$0.25$0.244.17%
2014-12-312015-02-26$981.53 million$0.28$0.280%
2014-09-302014-11-04$873.66 million$0.28$0.30-6.67%
2014-06-302014-07-31$1.11 billion$0.32$0.306.67%
2014-03-312014-05-06$1.1 billion$0.24$0.28-14.29%
2013-12-312014-02-27$1.01 billion$0.16
2013-09-302013-11-05$973.55 million$0.16
2013-06-302013-07-31$920.25 million$0.18
2013-03-312013-05-02$876.23 million$0.18
2012-12-312013-02-28$936.82 million$0.12
2012-09-302012-10-31$851.15 million$0.07$0.13-46.15%
2012-06-302012-07-31$779.05 million$0.08$0.27-70.37%
2012-03-312012-04-24$888.95 million$0.13
2011-12-312012-02-29$708.12 million$0.00
2011-09-302011-11-11$698.63 million$0.05
2011-06-302011-07-28$551.92 million-$0.03

Grifols, S.A (GRFS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Grifols, S.A (GRFS) Chart:

Grifols, S.A (GRFS) News:

Below you will find a list of latest news for Grifols, S.A (GRFS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Grifols, S.A (GRFS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-06-1810CALL0 00TRUE00
2026-06-1820CALL0 00TRUE00
2026-06-1830CALL0 0500.6TRUE00
2026-06-1840CALL0 0362.23TRUE00
2026-06-1850CALL0 0454.29TRUE00
2026-06-1860CALL0 00TRUE00
2026-06-1870.6CALL1 1109.47TRUE0.60
2026-06-1880CALL0 95218.06FALSE00
2026-06-1890.2CALL0 121299.92FALSE00
2026-06-18100CALL0 2367.84FALSE00
2026-06-18110CALL0 0423.74FALSE00
2026-06-18120CALL0 0471.47FALSE00
2026-06-18130CALL0 0513.19FALSE00
2026-06-18140CALL0 0550.26FALSE00
2026-06-18150CALL0 0583.61FALSE00
2026-06-18160CALL0 0613.9FALSE00
2026-06-18170CALL0 0641.65FALSE00
2026-06-1810.16PUT0 550FALSE00
2026-06-1820PUT0 21140.56FALSE00
2026-06-1830PUT0 4614.33FALSE00
2026-06-1840PUT0 4449.48FALSE00
2026-06-1850PUT0 1447.33FALSE00
2026-06-1860PUT0 0130.28FALSE00
2026-06-1870PUT0 48113.72FALSE00
2026-06-1880PUT0 84193.22TRUE00
2026-06-1891.6PUT0 20TRUE00
2026-06-18100PUT0 00TRUE00
2026-06-18110PUT0 0403.91TRUE00
2026-06-18120PUT0 0451.17TRUE00
2026-06-18130PUT0 0352.63TRUE00
2026-06-18140PUT0 0356.89TRUE00
2026-06-18150PUT0 0385.13TRUE00
2026-06-18160PUT0 0410.94TRUE00
2026-06-18170PUT0 0434.7TRUE00
2026-07-1710CALL0 00TRUE00
2026-07-1720CALL0 00TRUE00
2026-07-1730CALL0 00TRUE00
2026-07-1740CALL0 00TRUE00
2026-07-1750CALL0 00TRUE00
2026-07-1760CALL0 00TRUE00
2026-07-1770CALL0 087.89TRUE00
2026-07-1780CALL0 2065.71FALSE00
2026-07-1790CALL0 152.21FALSE00
2026-07-17100CALL0 066.87FALSE00
2026-07-17110CALL0 1175.38FALSE00
2026-07-17120CALL0 0193.98FALSE00
2026-07-17130CALL0 0210.24FALSE00
2026-07-17140CALL0 0224.68FALSE00
2026-07-17150CALL0 0237.67FALSE00
2026-07-1710PUT0 2695.84FALSE00
2026-07-1720PUT0 1437.4FALSE00
2026-07-1730PUT0 0314.54FALSE00
2026-07-1740PUT0 1233.2FALSE00
2026-07-1750PUT0 1171.19FALSE00
2026-07-1760PUT0 1119.36FALSE00
2026-07-1770PUT0 38125.42FALSE00
2026-07-1780PUT0 089.45TRUE00
2026-07-1790PUT0 063.3TRUE00
2026-07-17100PUT0 00TRUE00
2026-07-17110PUT0 0163.66TRUE00
2026-07-17120PUT0 0137.51TRUE00
2026-07-17130PUT0 0195.4TRUE00
2026-07-17140PUT0 0123.28TRUE00
2026-07-17150PUT0 0134.09TRUE00
2026-08-2110CALL0 00TRUE00
2026-08-2120CALL0 0393.09TRUE00
2026-08-2130CALL0 00TRUE00
2026-08-2140CALL0 00TRUE00
2026-08-2150CALL0 00TRUE00
2026-08-2160CALL0 057.11TRUE00
2026-08-2170CALL0 10083.93TRUE00
2026-08-2180CALL0 792100.51FALSE00
2026-08-2190CALL0 31452.7FALSE00
2026-08-21100CALL0 23580.94FALSE00
2026-08-21110CALL0 862.92FALSE00
2026-08-21120CALL0 7107.18FALSE00
2026-08-21130CALL0 4117.78FALSE00
2026-08-21140CALL0 2127.21FALSE00
2026-08-21150CALL0 0135.71FALSE00
2026-08-21160CALL0 0143.44FALSE00
2026-08-21170CALL0 0150.53FALSE00
2026-08-2110PUT0 0488.82FALSE00
2026-08-2120PUT0 0307.05FALSE00
2026-08-2130PUT0 0220.67FALSE00
2026-08-2140PUT0 0163.48FALSE00
2026-08-2150PUT0 0119.86FALSE00
2026-08-2160.1PUT1 449.49FALSE-0.1-0.5
2026-08-2170PUT0 1356.25FALSE00
2026-08-2180PUT0 22732.97TRUE00
2026-08-2190PUT0 3448.08TRUE00
2026-08-21100PUT0 00TRUE00
2026-08-21110PUT0 00TRUE00
2026-08-21120PUT0 0142.8TRUE00
2026-08-21130PUT0 0154.73TRUE00
2026-08-21140PUT0 0161.04TRUE00
2026-08-21150PUT0 0170.61TRUE00
2026-08-21160PUT0 0179.34TRUE00
2026-08-21170PUT0 0168.4TRUE00
2026-11-2010CALL0 00TRUE00
2026-11-2020CALL0 1211.78TRUE00
2026-11-2030CALL0 00TRUE00
2026-11-2040CALL0 00TRUE00
2026-11-2050CALL0 061.91TRUE00
2026-11-2060CALL0 070.57TRUE00
2026-11-2070CALL0 4050.55TRUE00
2026-11-2080CALL0 4991.04FALSE00
2026-11-2090CALL0 12999.02FALSE00
2026-11-20100.2CALL0 160105.21FALSE00
2026-11-20110CALL0 063.55FALSE00
2026-11-20120CALL0 071.48FALSE00
2026-11-20130CALL0 078.43FALSE00
2026-11-20140CALL0 084.61FALSE00
2026-11-20150CALL0 090.19FALSE00
2026-11-20160CALL0 095.26FALSE00
2026-11-2010PUT0 0321.6FALSE00
2026-11-2020PUT0 0201.63FALSE00
2026-11-2030PUT0 0144.67FALSE00
2026-11-2040PUT0 0106.95FALSE00
2026-11-2050PUT0 078.17FALSE00
2026-11-2060PUT0 4554.04FALSE00
2026-11-2070PUT0 196.76FALSE00
2026-11-2081.25PUT0 677.88TRUE00
2026-11-2090PUT0 078.97TRUE00
2026-11-20100PUT0 135.85TRUE00
2026-11-20110PUT0 00TRUE00
2026-11-20120PUT0 00TRUE00
2026-11-20130PUT0 00TRUE00
2026-11-20140PUT0 00TRUE00
2026-11-20150PUT0 067.72TRUE00
2026-11-20160PUT0 073.21TRUE00
2026-12-1830CALL0 140TRUE00
2026-12-1840CALL0 00TRUE00
2026-12-1850CALL0 652.26TRUE00
2026-12-1860CALL0 1087.01TRUE00
2026-12-1870CALL0 2185.46TRUE00
2026-12-1880CALL0 22291.77FALSE00
2026-12-1890CALL0 258.73FALSE00
2026-12-18100CALL0 116104.59FALSE00
2026-12-18110CALL0 666.06FALSE00
2026-12-18120CALL0 2066.21FALSE00
2026-12-18150CALL0 1674.31FALSE00
2026-12-18170CALL0 092.44FALSE00
2026-12-1830PUT0 0133.47FALSE00
2026-12-1840PUT0 098.62FALSE00
2026-12-1850PUT0 067.86FALSE00
2026-12-1860PUT0 3117.61FALSE00
2026-12-1870.95PUT0 1497.05FALSE00
2026-12-1880PUT0 1381.36TRUE00
2026-12-1890PUT0 065.7TRUE00
2026-12-18100PUT0 436.66TRUE00
2026-12-18110PUT0 00TRUE00
2026-12-18120PUT0 049.15TRUE00
2026-12-18150PUT0 062.94TRUE00
2026-12-18170PUT0 0128.66TRUE00

Latest GRFS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST24$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST142$11.835
Jun 13, 2022 7:59 PM EST10$11.83

Grifols, S.A (GRFS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001082/0000315066-19-001082-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001598/0000315066-19-001598-index.htm
2018-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918030037/0001104659-18-030037-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918031927/0001104659-18-031927-index.htm
2018-05-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918035864/0001104659-18-035864-index.htm
2018-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918037898/0001104659-18-037898-index.htm
2018-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918038773/0001104659-18-038773-index.htm
2018-06-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1438569/000110465918040970/0001104659-18-040970-index.htm
2018-07-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918047551/0001104659-18-047551-index.htm
2018-08-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918048670/0001104659-18-048670-index.htm
2018-09-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918055714/0001104659-18-055714-index.htm
2018-10-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918060259/0001104659-18-060259-index.htm
2018-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918064237/0001104659-18-064237-index.htm
2018-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065575/0001104659-18-065575-index.htm
2018-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065887/0001104659-18-065887-index.htm
2018-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069526/0001104659-18-069526-index.htm
2018-11-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069680/0001104659-18-069680-index.htm
2018-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918073562/0001104659-18-073562-index.htm
2018-12-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918075244/0001104659-18-075244-index.htm
2019-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919011270/0001104659-19-011270-index.htm
2019-03-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919013238/0001104659-19-013238-index.htm
2019-03-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919018669/0001104659-19-018669-index.htm
2019-04-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919020063/0001104659-19-020063-index.htm
2019-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919021489/0001104659-19-021489-index.htm
2019-04-2320-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919023085/0001104659-19-023085-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919026164/0001104659-19-026164-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919027308/0001104659-19-027308-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919031663/0001104659-19-031663-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919033920/0001104659-19-033920-index.htm
2019-07-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919039379/0001104659-19-039379-index.htm
2019-07-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919040426/0001104659-19-040426-index.htm
2019-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919042789/0001104659-19-042789-index.htm
2019-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919056835/0001104659-19-056835-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919057088/0001104659-19-057088-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919058031/0001104659-19-058031-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919062979/0001104659-19-062979-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919064554/0001104659-19-064554-index.htm
2019-11-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919065722/0001104659-19-065722-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070538/0001104659-19-070538-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070539/0001104659-19-070539-index.htm
2020-02-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920022273/0001104659-20-022273-index.htm
2020-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920026130/0001104659-20-026130-index.htm
2020-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920038405/0001104659-20-038405-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920039290/0001104659-20-039290-index.htm
2020-04-0620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465920043470/0001104659-20-043470-index.htm
2020-04-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920049070/0001104659-20-049070-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920057912/0001104659-20-057912-index.htm
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2020-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920084649/0001104659-20-084649-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920088132/0001104659-20-088132-index.htm
2020-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102386/0001104659-20-102386-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102797/0001104659-20-102797-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920110940/0001104659-20-110940-index.htm
2020-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920113682/0001104659-20-113682-index.htm
2020-10-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920116641/0001104659-20-116641-index.htm
2020-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920121561/0001104659-20-121561-index.htm